首页> 外文OA文献 >The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals

【2h】

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals

机译：沙登和芙蓉医院在药物治疗依从性门诊接受华法林二次卒中预防的房颤患者的临床疗效评价

页面导航

著录项
相似文献
相关主题

著录项

作者
Mochamad Djunaedi Mochamad Djunaedi;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperati [J] . Yamaguchi T Stroke: A Journal of Cerebral Circulation . 2000,第4期

机译：华法林用于非瓣膜性房颤患者继发性卒中的最佳治疗强度：一项多中心，前瞻性，随机试验。日本非瓣膜性心房颤动-代谢二级预防合作社
2. The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation: A PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) substudy [J] . Viles-GonzalezJ.F., KarS., DouglasP., Journal of the American College of Cardiology . 2012,第10期

机译：使用watchman装置不完全闭合左心耳对心房颤动的临床影响：A PROTECT AF（经皮华氏闭合性左心耳封堵与华法林预防心房颤动的卒中治疗）亚研究
3. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE trial (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation): Predictors, characteristics, and clinical outcomes [J] . HylekE.M., HeldC., AlexanderJ.H., Journal of the American College of Cardiology . 2014,第20期

机译：接受阿哌沙班或华法林治疗的房颤患者的大出血：ARISTOTLE试验（阿哌沙班用于减少房颤中风和其他血栓栓塞事件）：预测因素，特征和临床结果
4. Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients [C] . Shijing Guo, Xiang Li, Xin Du, MEDINFO . 2017

机译：基于组的术语轨迹分析，用于高级患者的华法林治疗
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Effective INR Level May Be Delayed in Secondary Prevention of Stroke Due to Atrial Fibrillation with Warfarin in the Patients with Diabetes Mellitus [O] . Türkan Acar, Yeşim güzey Aras, Sıdıka sinem Gül, 2019

机译：糖尿病患者华法林引起的房颤继发性卒中的二级预防可能会延迟有效INR水平
7. The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation A PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Substudy [O] . Viles-Gonzalez Juan F., Kar Saibal, Douglas Pamela, 2012

机译：使用Watchman装置不完全闭合左心耳对房颤患者的临床影响A PROTECT AF（对心房颤动患者行经皮左心耳封闭术与华法林联合预防卒中）的研究

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals

著录项

相似文献

相关主题

期刊订阅